{"id":"https://openalex.org/W4383907735","doi":"https://doi.org/10.2147/ott.s374489","title":"Clinical Utility of Mobocertinib in the Treatment of NSCLC \u2013 Patient Selection and Reported Outcomes","display_name":"Clinical Utility of Mobocertinib in the Treatment of NSCLC \u2013 Patient Selection and Reported Outcomes","publication_year":2023,"publication_date":"2023-07-01","ids":{"openalex":"https://openalex.org/W4383907735","doi":"https://doi.org/10.2147/ott.s374489","pmid":"https://pubmed.ncbi.nlm.nih.gov/37456145","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10349594"},"language":"en","primary_location":{"id":"doi:10.2147/ott.s374489","doi":"https://doi.org/10.2147/ott.s374489","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s374489","pdf_url":"https://www.dovepress.com/getfile.php?fileID=91090","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=91090","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029353238","display_name":"Abram Arnold","orcid":"https://orcid.org/0000-0001-6017-9071","observed_orcids":["https://orcid.org/0000-0001-6017-9071"]},"institutions":[{"id":"https://openalex.org/I4210155874","display_name":"VA Nebraska Western Iowa Health Care System","ror":"https://ror.org/0594ske86","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210117924","https://openalex.org/I4210155874"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abram Arnold","raw_affiliation_strings":["Department of Medicine, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, NE, USA"],"raw_orcid":"https://orcid.org/0000-0001-6017-9071","affiliations":[{"raw_affiliation_string":"Department of Medicine, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, NE, USA","institution_ids":["https://openalex.org/I4210155874"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024497224","display_name":"Apar Kishor Ganti","orcid":"https://orcid.org/0000-0003-3724-2671","observed_orcids":["https://orcid.org/0000-0003-3724-2671"]},"institutions":[{"id":"https://openalex.org/I4210155874","display_name":"VA Nebraska Western Iowa Health Care System","ror":"https://ror.org/0594ske86","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210117924","https://openalex.org/I4210155874"]},{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Apar Kishor Ganti","raw_affiliation_strings":["Division of Oncology/Hematology, Department of Internal Medicine, Veterans Affairs Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, USA"],"raw_orcid":"https://orcid.org/0000-0003-3724-2671","affiliations":[{"raw_affiliation_string":"Division of Oncology/Hematology, Department of Internal Medicine, Veterans Affairs Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, USA","institution_ids":["https://openalex.org/I4210155874","https://openalex.org/I59130452"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5024497224"],"corresponding_institution_ids":["https://openalex.org/I4210155874","https://openalex.org/I59130452"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":0.2223,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.26357354,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"Volume 16","issue":null,"first_page":"559","last_page":"569"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mobocertinib","display_name":"mobocertinib","score":1.0},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9229999780654907},{"id":"https://openalex.org/keywords/egfr-exon-20-insertion-mutation","display_name":"EGFR exon 20 insertion","score":0.9559999704360962},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8989999890327454},{"id":"https://openalex.org/keywords/osimertinib","display_name":"osimertinib","score":0.7760000228881836},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.8690000176429749},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.859000027179718},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.6499999761581421},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8410000205039978},{"id":"https://openalex.org/keywords/accelerated-approval","display_name":"accelerated approval","score":0.671999990940094}],"concepts":[{"id":"https://openalex.org/C81917197","wikidata":"https://www.wikidata.org/wiki/Q628760","display_name":"Selection (genetic algorithm)","level":2,"score":0.5581353306770325},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.555557906627655},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3437783420085907},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3413226008415222},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.23379653692245483},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.176579087972641}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.2147/ott.s374489","doi":"https://doi.org/10.2147/ott.s374489","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s374489","pdf_url":"https://www.dovepress.com/getfile.php?fileID=91090","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10349594","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10349594","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10349594/pdf/ott-16-559.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Onco Targets Ther","raw_type":"Text"},{"id":"pmid:37456145","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37456145","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:dovepress.com/85062","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/clinical-utility-of-mobocertinib-in-the-treatment-of-nsclc--patient-se-peer-reviewed-fulltext-article-OTT","pdf_url":"https://www.dovepress.com/article/download/85062","source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Review"}],"best_oa_location":{"id":"doi:10.2147/ott.s374489","doi":"https://doi.org/10.2147/ott.s374489","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s374489","pdf_url":"https://www.dovepress.com/getfile.php?fileID=91090","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4383907735.pdf","grobid_xml":"https://content.openalex.org/works/W4383907735.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1967394241","https://openalex.org/W2005216767","https://openalex.org/W2036926586","https://openalex.org/W2838798742","https://openalex.org/W3129535020","https://openalex.org/W3132930574","https://openalex.org/W3191219220","https://openalex.org/W3199359439","https://openalex.org/W3202658232","https://openalex.org/W3206796634","https://openalex.org/W4223963763","https://openalex.org/W4239019305","https://openalex.org/W4280651624","https://openalex.org/W4281739620","https://openalex.org/W4293919117","https://openalex.org/W4296025800","https://openalex.org/W4297860588","https://openalex.org/W4304632324","https://openalex.org/W4315754639","https://openalex.org/W4362716531"],"related_works":["https://openalex.org/W4393044121","https://openalex.org/W3206796634","https://openalex.org/W4310458966","https://openalex.org/W3136657158","https://openalex.org/W4406923629","https://openalex.org/W4401929423","https://openalex.org/W6992756671","https://openalex.org/W4293919117","https://openalex.org/W3132930574","https://openalex.org/W3089052367"],"abstract_inverted_index":{"Mobocertinib":[0],"is":[1,21,61],"an":[2,89,160],"oral":[3],"tyrosine":[4],"kinase":[5],"inhibitor":[6],"(TKI)":[7],"that":[8,265],"selectively":[9],"targets":[10,31],"epidermal":[11],"growth":[12],"factor":[13],"receptor":[14],"exon":[15],"20":[16],"insertion":[17],"(EGFRex20ins)":[18],"mutations.":[19],"It":[20],"a":[22,64],"structural":[23],"analog":[24],"of":[25,58,72,95,175,191,242,270],"the":[26,54,70,232,240,268],"third-generation":[27],"TKI":[28],"osimertinib,":[29],"which":[30,165],"EGFR":[32,215],"T790M":[33],"mutant":[34],"non-small":[35],"cell":[36],"lung":[37],"cancer":[38],"(NSCLC);":[39],"however,":[40],"mobocertinib":[41,84,210,238],"gains":[42],"selectivity":[43],"for":[44,237],"EGFRex20ins":[45,251],"mutants":[46],"over":[47],"wild":[48],"type":[49],"(WT)":[50],"by":[51],"interacting":[52],"with":[53,111,140,154,170,244,250],"C790":[55],"gatekeeper":[56],"residue":[57],"EGFR.":[59],"This":[60],"accomplished":[62],"via":[63],"carboxylated":[65],"isopropyl":[66],"ester":[67],"moiety":[68],"at":[69],"C5-position":[71],"mobocertinib's":[73],"central":[74],"pyrimidine":[75],"core.":[76],"In":[77,229],"Phase":[78],"1/2":[79],"dose-escalation":[80],"and":[81,101,110,130,139,158,198,217,225],"dose-expansion":[82],"studies,":[83],"was":[85,121],"found":[86,182],"to":[87,185,195,209,213,267],"have":[88,186],"investigator-confirmed":[90],"overall":[91],"response":[92],"rate":[93],"(ORR)":[94],"56%":[96],"(9/16;":[97],"95%":[98,104],"CI:":[99,105,125,134],"30-80%)":[100],"25%":[102],"(3/12;":[103],"5-57%)":[106],"in":[107,136,189,239],"patients":[108,137,149,167,243],"without":[109,138],"baseline":[112,141],"brain":[113,142],"metastasis,":[114,143],"respectively.":[115,144],"Median":[116],"investigator-assessed":[117],"progression-free":[118],"survival":[119],"(mPFS)":[120],"10.2":[122],"months":[123,132],"(95%":[124,133],"5.6":[126],"-":[127],"not":[128],"reached)":[129],"3.7":[131],"1.8-15.9)":[135],"A":[145],"third":[146],"phase":[147],"evaluated":[148,166],"who":[150],"had":[151],"received":[152],"pre-treatment":[153],"platinum-based":[155,258],"chemotherapy":[156],"(PPP)":[157],"included":[159],"extension":[161],"cohort":[162],"(EXCLAIM":[163],"cohort)":[164],"treated":[168],"previously":[169],"1":[171],"or":[172,201,247],"2":[173],"lines":[174],"therapy.":[176],"An":[177],"Independent":[178],"Review":[179],"Committee":[180],"(IRC)":[181],"both":[183],"cohorts":[184],"similar":[187,212],"outcomes":[188],"terms":[190],"ORR,":[192],"median":[193],"time":[194],"response,":[196],"mPFS,":[197],"disease":[199,254],"progression":[200],"death.":[202],"The":[203,260],"treatment-emergent":[204],"adverse":[205],"events":[206],"(TEAE)":[207],"related":[208],"are":[211,218],"other":[214],"inhibitors":[216],"predominately":[219],"gastrointestinal":[220],"(eg":[221,227],"diarrhea,":[222],"nausea,":[223],"vomiting)":[224],"cutaneous":[226],"rash).":[228],"September":[230],"2021,":[231],"FDA":[233],"granted":[234],"accelerated":[235],"approval":[236,269],"treatment":[241],"locally":[245],"advanced":[246],"metastatic":[248],"NSCLC":[249],"mutation":[252],"whose":[253],"progressed":[255],"while":[256],"on":[257],"chemotherapy.":[259],"present":[261],"review":[262],"describes":[263],"data":[264],"led":[266],"mobocertinib.":[271]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-07-12T00:00:00"}